Improving the lives of people with dementia

Building Tomorrow Together – Innovation In Dementia

Improving the lives of people with dementia

Building Tomorrow Together
- Innovation In Dementia

Roche

Type
Open Innovation

Area
Health

Purpose
Finding digital solutions to improve the quality of life of people with dementia.

Worldwide, 50 million people are living with Alzheimer’s disease and other dementias. Roche was committed to finding digital health solutions covering the entire patient journey.

Building Tomorrow Together – Innovation in Dementia, a collaborative innovation project by Roche, was created to bring together several key players in the health ecosystem.

The program gathered, for the first time, private, public and philanthropic organizations to power an ecosystem and the collaboration between all stakeholders and startups from all geographies to develop and introduce innovative technologies that will support healthcare providers and improve patients’ lives and their caregivers.

Key Results

Pilot Projects

Care Providers

Solutions

Startups
Centro Hospitalar de Entre o Douro e Vouga
CNS
Cuf
Lusíadas
Luz Saúde
São João

Building Tomorrow Together – Innovation in Dementia

The Impact

Lusíadas and Virtuleap

Revolutionizing Neuropsychological Testing

Virtuleap is collaborating with Lusíadas Hospital in a virtual reality solution that digitalizes neuropsychological tests for Alzheimer’s patients. This innovative technology enhances diagnostic accuracy and supports more effective treatment planning for those living with Alzheimer’s disease.

Hospital entre o Douro e Vouga, NeoNeuro

Simplifying Alzheimer’s Diagnosis

NeoNeuro’s pilot program with Centro Hospitalar de Entre Douro e Vouga aims to simplify the Alzheimer’s diagnosis process by using an innovative blood test. This test detects amyloid levels through neuro-aptamers, providing a faster and more accurate approach to diagnosing the disease.

Luz Saúde, São João and iLoF

30-Second Alzheimer’s Detection

iLoF, in partnership with Hospital São João and Luz Saúde Group, tested an under-30-second Alzheimer’s diagnosis using AI and photonic science. By creating a digital biomarker library from blood samples, this non-invasive solution offers accurate and rapid dementia diagnosis, setting a new standard for early detection.

CUF, CNS and Somatix

Wearables to Improve Dementia Patient Care

Somatix’s AI-powered smart wristband, tested by CNS and CUF, offers remote monitoring of dementia patients to improve safety, well-being, and autonomy. By reducing caregiver burden, as well as hospitalizations and infections, this solution is transforming dementia care and helping improve the quality of life for patients and their families.

Want to know more about
similar services?

Visit our Services page

It’s time to grow your business
with collaborative innovation.

I want to talk to the Beta-i team